Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134986) titled 'Efficacy and Safety of Zonisamide as First-add-on Treatment in Focal Epileptic Seizures or Secondary Generalized Tonic-Clonic SeizuresA Clinical Study' on Oct. 22.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Affiliated Hospital of Nantong University
Condition:
Focal Epileptic Seizures, Secondary Generalized Tonic-Clonic Seizures
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2024-11-26
Target Sample Size: Experimental group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=288007
Disclaimer: Curated...